SUBSCRIBE
SUBSCRIBE
News   Policy

U.S. Lawmaker Questions FDA, Cites Industry Ties

September 18, 2008 | 
1 min read

WASHINGTON (Reuters) - The U.S. Food and Drug Administration appears to be giving priority to projects that benefit the pharmaceutical industry rather than helping consumers, a top Democratic lawmaker said on Wednesday.

Regulatory
MORE ON THIS TOPIC
Roche's signage at its office in France
Approvals
Roche Wins First-Line Breast Cancer Nod for Oral PI3K Blocker, Projects $2.3B in Peak Sales
October 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Teva Pharmaceuticals USA headquarters in
Legal
Teva to Pay $450M in Settlement With DOJ Over Kickback and Price-Fixing Allegations
October 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Drug Development
How AI Could Ease Tension in Clinical Trials
October 10, 2024
 · 
1 min read
 · 
Lori Ellis
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
Third-Party Issues Delay Zealand’s Congenital Hyperinsulinism Drug
October 10, 2024
 · 
188 min read
 · 
Heather McKenzie